High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage (Q43872552)

27 November 2017

High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage (English)

1 reference

27 November 2017

0 references

1 reference

5

Lesley Regan

1 reference

27 November 2017

Luciano G Nardo

1

1 reference

27 November 2017

Raj Rai

series ordinal

2

1 reference

27 November 2017

May Backos

series ordinal

3

1 reference

27 November 2017

Safaa El-Gaddal

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

27 November 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

Fertility and Sterility

1 reference

27 November 2017

77

1 reference

27 November 2017

2

1 reference

27 November 2017

348-352

1 reference

27 November 2017

Recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Adverse effects of luteinizing hormone on fertility: fact or fantasy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Is endometrial development in the peri-implantation period influenced by high concentrations of luteinizing hormone in the follicular phase?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Reproductive failure due to spontaneous abortion and recurrent miscarriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Follicular dynamics in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Hypersecretion of luteinising hormone, infertility, and miscarriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Ultrasound diagnosis of polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

ACP Broadsheet no 136: February 1993. Detection and importance of anticardiolipin antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Polycystic ovaries and recurrent miscarriage--a reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Pregnancy outcome following exposure to gonadotrophin-releasing hormone analogue during early pregnancy: comparisons in patients with normal or elevated luteinizing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

The effect of serum follicular phase luteinizing hormone concentrations in habitual abortion: correlation with results of paternal leukocyte immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Obesity is a risk factor for early pregnancy loss after IVF or ICSI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902995-8

10.1016/S0015-0282(01)02995-8

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference